Successful Afatinib Therapy after Resistance to EGFR-TKI in a Patient with Advanced Adenosquamous Cell Lung Cancer

被引：4

作者：

Tamura, Tomohiro ^{[1
]}

Kagohashi, Katsunori ^{[1
]}

Satoh, Hiroaki ^{[1
]}

机构：

[1] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2015年 / 38卷 / 06期

关键词：

Lung cancer; Afatinib; Resistance; EGFR-TKI; Adenosquamous cell lung cancer; Rechallenge; MUTATION;

D O I：

10.1159/000431351

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：316 / +

页数：2

共 4 条

[1]

Bordi Paola, 2014, Tumori, V100, pe20, DOI 10.1700/1430.15832

[2] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor [J].

Kim, Youngwook ;

Ko, Jeonghun ;

Cui, ZhengYun ;

Abolhoda, Amir ;

Ahn, Jin Seok ;

Ou, Sai-Hong ;

Ahn, Myung-Ju ;

Park, Keunchil .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :784-791

[3] Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment [J].

Kuiper, Justine L. ;

Heideman, Danielle A. M. ;

Wurdinger, Tom ;

Grunberg, Katrien ;

Groen, Harry J. M. ;

Smit, Egbert F. .

CLINICAL LUNG CANCER, 2015, 16 (01) :60-66

[4] Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib [J].

Schuler, Martin ;

Fischer, Juergen R. ;

Grohe, Christian ;

Guetz, Sylvia ;

Thomas, Michael ;

Kimmich, Martin ;

Schneider, Claus-Peter ;

Laack, Eckart ;

Maerten, Angela .

ONCOLOGIST, 2014, 19 (10) :1100-1109

← 1 →